65,437 trials
Prolonged QTc Interval
Primary: Maximum Difference in Change From Baseline in ddQTcF Following a Single Dose of 33 mg/kg Deferiprone — 1.4; -1.6 milliseconds
Breast Cancer · Diagnostic Imaging
Primary: Difference for Sensitivity for Detection of Full Extent of Malignant Breast Disease Using CMRM vs UMRM Per Reader — 46.6; 30.8; 23.3; 17.8 difference in sensitivity (%)
Chronic Heart Failure (CHF)
Primary: Cohort Retention — 16; 7 participants
Endotracheal Intubation
Primary: In the Present Study we Will Compare the Performance Parameters of Intubation Using Etview Tracheoscopic Ventilation Tube - TVT to the Standard Tube
Non-Small Cell Lung Cancer
Primary: Percentage of Participants With Disease Progression or Death — 72.1; 76.2 percentage of participants
Relapsing Forms of Multiple Sclerosis
Primary: Worst Severity Score of Overall Gastrointestinal (GI) Events, Modified Overall GI Symptom Scale (MOGISS) — 4.8 units on a scale
Breast Cancer
Primary: Difference of Sensitivity for Detection of Full Extent of Malignant Breast Disease Using CMRM vs UMRM Per Reader — 15.2; 31.9; 30.4; 15.9 difference in sensitivity (%)
Type 2 Diabetes Mellitus
Primary: Increased HDL-Cholesterol and Decreased Triglycerides — 7.9; 2.7; 15.7; -1.5 % Change — p=0.05
Gaucher Disease
Primary: Hemoglobin — 1.2; 0.4; 1.1; 1.5 g/dL
Pulmonary Disease · COPD · Chronic Bronchitis
Primary: Effect of Intervention on Quality of Patient Clinician Communication About End-of-Life Care(QOC) Scale — 23.3; 19.2; 34.0; 25.5 units on a scale — p=0.03
Major Depressive Disorder
Primary: Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score After 8 Weeks of Treatment — -15.84; -14.85; -13.81 scores on a scale — p=0.1031
Schizophrenia
Primary: Percentage of Stable Participants at Baseline Who Remained Stable at Endpoint (Last Visit). — 100; 99.02; 99.14; 98.51 Percentage of participants
Meningitis · Meningococcal Disease
Primary: Summary of Diagnoses With Significantly Elevated Findings From Risk-Window vs. Control-Window Comparisons: All Ages Combined - Short-Term Passive Surveillance — 0.98…
Gastroesophageal Reflux Disease With Dyspepsia Symptoms
Primary: Subjective Symptom Improvement Rate — 75.7; 73.5; 68.6; 65.3 percentage of participants
Alcohol Dependence
Primary: Treatment Engagement — 36; 9 percentage of participants engaged